427 related articles for article (PubMed ID: 19578105)
21. Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity.
Kuryliszyn-Moskal A; Ciolkiewicz M; Klimiuk PA; Sierakowski S
Scand J Rheumatol; 2009; 38(1):38-45. PubMed ID: 18991188
[TBL] [Abstract][Full Text] [Related]
22. Cryptococcosis in systemic lupus erythematosus: a series of six cases.
González LA; Vásquez G; Restrepo JP; Velásquez M; Ramírez LA
Lupus; 2010 Apr; 19(5):639-45. PubMed ID: 20118161
[TBL] [Abstract][Full Text] [Related]
23. Lupus enteritis: clinical characteristics, risk factor for relapse and association with anti-endothelial cell antibody.
Kwok SK; Seo SH; Ju JH; Park KS; Yoon CH; Kim WU; Min JK; Park SH; Cho CS; Kim HY
Lupus; 2007; 16(10):803-9. PubMed ID: 17895303
[TBL] [Abstract][Full Text] [Related]
24. Incidence and risk factors of infection in a single cohort of 110 adults with systemic lupus erythematosus.
Jeong SJ; Choi H; Lee HS; Han SH; Chin BS; Baek JH; Kim CO; Choi JY; Song YG; Kim JM
Scand J Infect Dis; 2009; 41(4):268-74. PubMed ID: 19172435
[TBL] [Abstract][Full Text] [Related]
25. Infection in systemic lupus erythematosus.
Khalifa M; Kaabia N; Bahri F; Ben Jazia E; Bouajina E; Omezzine Letaief A
Med Mal Infect; 2007 Dec; 37(12):792-5. PubMed ID: 17870271
[TBL] [Abstract][Full Text] [Related]
26. Lymphopenia at presentation is associated with increased risk of infections in patients with systemic lupus erythematosus.
Ng WL; Chu CM; Wu AK; Cheng VC; Yuen KY
QJM; 2006 Jan; 99(1):37-47. PubMed ID: 16371405
[TBL] [Abstract][Full Text] [Related]
27. Herpes zoster infections in systemic lupus erythematosus: risk factors and outcome.
Kahl LE
J Rheumatol; 1994 Jan; 21(1):84-6. PubMed ID: 8151595
[TBL] [Abstract][Full Text] [Related]
28. Systemic lupus erythematosus and infection: a controlled and prospective study including an epidemiological group.
Nived O; Sturfelt G; Wollheim F
Q J Med; 1985 Jun; 55(218):271-87. PubMed ID: 4023171
[TBL] [Abstract][Full Text] [Related]
29. Salmonella infections in patients with systemic lupus erythematosus: a case series.
Gerona JG; Navarra SV
Int J Rheum Dis; 2009 Dec; 12(4):319-23. PubMed ID: 20374369
[TBL] [Abstract][Full Text] [Related]
30. Skin denervation and cutaneous vasculitis in systemic lupus erythematosus.
Tseng MT; Hsieh SC; Shun CT; Lee KL; Pan CL; Lin WM; Lin YH; Yu CL; Hsieh ST
Brain; 2006 Apr; 129(Pt 4):977-85. PubMed ID: 16415307
[TBL] [Abstract][Full Text] [Related]
31. Long-term outcome and short-term survival of patients with systemic lupus erythematosus after bacteraemia episodes: 6-yr follow-up.
Chen MJ; Tseng HM; Huang YL; Hsu WN; Yeh KW; Wu TL; See LC; Huang JL
Rheumatology (Oxford); 2008 Sep; 47(9):1352-7. PubMed ID: 18565988
[TBL] [Abstract][Full Text] [Related]
32. Clinical characteristics and outcomes of the meningitides in systemic lupus erythematosus.
Baizabal-Carvallo JF; Delgadillo-Márquez G; Estañol B; García-Ramos G
Eur Neurol; 2009; 61(3):143-8. PubMed ID: 19092250
[TBL] [Abstract][Full Text] [Related]
33. Angiogenic activity in sera of patients with systemic lupus erythematosus.
Sakly N; Mirshahi P; Ducros E; Soria J; Ghedira I; Mirshahi M
Lupus; 2009 Jul; 18(8):705-12. PubMed ID: 19502266
[TBL] [Abstract][Full Text] [Related]
34. [Study on the clinical epidemiology of systemic lupus erythematosus among 1433 cases].
Zhang YQ; Ye DQ; Li XP; Zhang GQ; Fang YR; Yin J; Yang SG; Hu YS
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Feb; 26(2):128-31. PubMed ID: 15921616
[TBL] [Abstract][Full Text] [Related]
35. Low dose intravenous immunoglobulin in systemic lupus erythematosus: analysis of 62 cases.
Sherer Y; Kuechler S; Jose Scali J; Rovensky J; Levy Y; Zandman-Goddard G; Shoenfeld Y
Isr Med Assoc J; 2008 Jan; 10(1):55-7. PubMed ID: 18300575
[TBL] [Abstract][Full Text] [Related]
36. Clinical and bacteriologic study of eighty-six patients with systemic lupus erythematosus complicated by infections.
Li Z; Chen L; Tao R; Fan X
Chin Med J (Engl); 1998 Oct; 111(10):913-6. PubMed ID: 11189239
[TBL] [Abstract][Full Text] [Related]
37. Analysis of 15 patients with systemic lupus erythematosus manifesting with negative immunofluorescence anti-nuclear antibodies after treatment.
Song LJ; Ding F; Liu HX; Shu Q; Yu X; Li J; Li XF
Lupus; 2012 Jul; 21(8):919-24. PubMed ID: 22187164
[TBL] [Abstract][Full Text] [Related]
38. Septic arthritis in patients with systemic lupus erythematosus: salmonella and nonsalmonella infections compared.
Huang JL; Hung JJ; Wu KC; Lee WI; Chan CK; Ou LS
Semin Arthritis Rheum; 2006 Aug; 36(1):61-7. PubMed ID: 16887469
[TBL] [Abstract][Full Text] [Related]
39. Lymphopenia as risk factor for development of severe infections in patients with systemic lupus erythematosus: a case-control study.
Merayo-Chalico J; Gómez-Martín D; Piñeirúa-Menéndez A; Santana-De Anda K; Alcocer-Varela J
QJM; 2013 May; 106(5):451-7. PubMed ID: 23458779
[TBL] [Abstract][Full Text] [Related]
40. Usefulness of erythrocyte-bound C4d as a biomarker to predict disease activity in patients with systemic lupus erythematosus.
Yang DH; Chang DM; Lai JH; Lin FH; Chen CH
Rheumatology (Oxford); 2009 Sep; 48(9):1083-7. PubMed ID: 19553377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
